GIST Mutation Detection Kit Market

The global GIST Mutation Detection Kit Market Size was USD 409.4 million in 2024 and the market is projected to touch USD 574.2 million by 2031, exhibiting a CAGR of 5.80% during the forecast period.

GIST occurs habitually in the small intestine and stomach that develop in the cell to form a special type of nerve cells. The GIST is one of the types of cancer that starts in the digestive system. Mutation happens when the DNA sequences undergo changes from its base-pairs sequence which usually produce recessive genes. Detection kit for GIST is a screening panel used to identify the presence of somatic mutation in c-kit and PDGFRA genes.

With the increase in GIST incidence worldwide as well as increasing awareness and its treatments among healthcare providers and patients driving the market of detection kits for GIST mutation.

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic has propelled in the growth of this market due to the progress of new technologies and innovations in the mutation detection kit market. Its demand increases in a variety of settings and likely to continue in the coming years for organizations to develop quality and safe devices. In the pandemic, this market also had a phase of slow growth due to decelerate of the supply and other areas which are related with this market are highly affected such as production, manufacturing units and others.

The latest trend of the detection kit market is the involvement of advanced technology. The new technology helps in focusing more on the nature of ailments. With the innovative development of detection tools reduce the need for multiple trips to different hospitals.

GIST MUTATION DETECTION KIT MARKET SEGMENTATION

By Type

Based on type the market can be categorized into PDGFRA & C-KIT

• PDGFRA: This type of mutation is related to GIST which occurs in the stomach. This is a rare disease that affects the production of cells in the gastrointestinal tract well-known as interstitial cells of Cajal (ICC). ICCs help in moving food and liquid through the gut.
• C-KIT: The c-kit mutation was an independent prognostic factor for overall and cause-specific survival of the patients with GISTs. This act both as a proto-oncogene and tumor suppressor through kinase activity and dependence receptor activity respectively.

By Application

Based on application the market can be categorized into Medical, Research, & Others

• Medical: In this medical application type of this market is the availability of the treatment and detection for the disease. The hospitals have experts to diagnose the conditions of the individual. This application segment helps in the growth of the market.
• Research: In this application segment, the GIST is a rare type of disease and needs more understanding and awareness. Hence, the research application segment is helping the market to grow significantly.
• Others: There are other application segments apart from medical and research that are involved in the detection kit for the GIST mutation such as clinic and medical institute and other organizations.

"Increasing Demand of Effective tools Increases the Market Extremely"

It is one of the key driving factors for the GIST Mutation Detection Kit Market Growth due to increasing demand of incidence of GIT globally. To identify GIST is difficult and the unmet medical needs for effective and reliable tools for the detection is very important and new technology development has increased the market growth.

"Increasing Awareness of GIST Encourages the Market Growth"

The other factor that helps in increasing the market growth is the increasing awareness of this rare disease and its treatment among the patients and healthcare providers. The governments are also providing necessary support for research and development which helps in further growth of this market.

"Lengthy Approval Process Restrict the Market Growth"

Some of the restraining factors for this market to grow include the cost of GIST detection is very high and limited access for some patients. As this type of cancer is rare, the market is small. Some patients may develop resistance to the TKI which limits the effectiveness of this kit. The approval process for new products is lengthy and expensive.

GIST MUTATION DETECTION KIT MARKET REGIONAL INSIGHTS

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

"North America Dominates the Market due to Increase in Number of Patients"

The North America region is dominating the GIST Mutation Detection Kit Market Share due to the increase in number of patients. There is a large and aging patients’ population and high levels of healthcare spending and pharmaceutical companies. The U.S. is the largest market for this region accounting for the majority of sales. Due to the increasing use of advanced technology the demand is also growing for effective treatment. Asia Pacific is also growing rapidly due to the increase in the number of incidences of GIST. The growing awareness and healthcare treatment help this market to grow.

Key players in the mutation detection kit market are influential companies that play a significant role in shaping the industry and drive its growth. These players are often at the forefront of the technological advancements, product innovation, and market trends.

• EntroGen (U.S.)
• Bio-Rad (U.S.)
• AmoyDx (China)
• MCLAB (China)
• Thermo Fisher Scientific (U.S.)
• LCM Genect (Italy)
• NimaGen (Netherlands)
• Beyotime Biotechnology (China)
• Genetron Health (China)
• Jiangsu MicroDiag Biomedicine Technology (China)
• HELIXGEN (Guangzhou) (China)
• Geneseeq (Canada)
• ASBACH MEDICAL PRODUCTS GMBH (AMP) (Germany)
• Diogene (Swizerland)
• 3B BlackBio Biotech India (India)
• Panagene (South Korea)
• Medaysis (U.S.)

June 2022: Taiho Pharmaceutical Co., Ltd in Japan has announced the sanction for manufacturing and promotion the oral heat shock protein inhibitor Jeselhy tables from the government of Japan. This tablet is used for the indication of GIST that has progressed after chemotherapy.

This report is based on historical analysis and forecast calculation that aims to help readers get a comprehensive understanding of the global GIST mutation detection kit market from multiple angles, which also provides sufficient support to readers’ strategy and decision-making. Also, this study comprises a comprehensive analysis of SWOT and provides insights for future developments within the market. It examines varied factors that contribute to the growth of the market by discovering the dynamic categories and potential areas of innovation whose applications may influence its trajectory in the upcoming years. This analysis encompasses both recent trends and historical turning points into consideration, providing a holistic understanding of the market’s competitors and identifying capable areas for growth.

This research report examines the segmentation of the market by using both quantitative and qualitative methods to provide a thorough analysis that also evaluates the influence of strategic and financial perspectives on the market. Additionally, the report's regional assessments consider the dominant supply and demand forces that impact market growth. The competitive landscape is detailed meticulously, including shares of significant market competitors. The report incorporates unconventional research techniques, methodologies and key strategies tailored for the anticipated frame of time. Overall, it offers valuable and comprehensive insights into the market dynamics professionally and understandably.